secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMERICA INC (BMRA)
CIK:        0000073290
Form:       8-K
Filed at:   2025-10-08T23:59:59+00:00
Accession:  0001493152-25-017363
Event type: leadership
Sentiment:  positive
Materiality: 0.55
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomerica appoints former LabCorp Diagnostics CEO Gary Huff to board; director Emerson not standing for re-election
--------------------------------------------------------------------------------

- Gary Huff appointed as independent director effective Oct 7, 2025; will serve on Audit, Comp, and Governance committees.
- Huff receives annualized cash fee of $45,000 (paid quarterly); no equity compensation granted for board appointment.
- Dr. Jane Emerson to step down after 18 years on board, not seeking re-election at Dec 12, 2025 annual meeting; board size to reduce to 5.
- Huff brings 35+ years of lab industry experience, having served as CEO of LabCorp Diagnostics and Baylor Genetics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/73290/000149315225017363/0001493152-25-017363-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/73290/000149315225017363/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-017363

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer